Andriani L, Ling YX, Yang SY, Zhao Q, et al. Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting the TOLLIP-mediated autophagic degradation of CIP2A. Cancer Lett 2024 Jun 5:217008. doi: 10.1016/j.canlet.2024.217008.
PMID: 38849012